Healthcare professional and patient views, behaviours and experiences surrounding novel oral anticoagulants (NOACs) for the management of non-valvular atrial fibrillation (AF): a systematic review protocol. [Protocol]
Stewart, Derek C.
Leslie, Stephen James
Rushworth, Gordon F.
MetadataShow full item record
STEWART, D., GENERALOVA, D., CUNNINGHAM, S., LESLIE, S., RUSHWORTH, G. and MCIVER, L. 2016. Healthcare professional and patient views, behaviours and experiences surrounding novel oral anticoagulants (NOACs) for the management of non-valvular atrial fibrillation (AF): a systematic review protocol. [Protocol]. PROSPERO [online], CRD42016003840. Available from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016003840
While there is a wealth of evidence on aspects such as efficacy, effectiveness, cost-effectiveness and safety, there is less evidence on the use of NOACs in clinical practice. A scoping search of MEDLINE for the years 2007-2015 has identified a number of relevant primary research. However, to date, no systematic reviews of health professional or patient views, behaviours and experiences have been published. Furthermore, a search of the Cochrane Collaboration, the Centre for Reviews and Dissemination and the Joanna Briggs Institute did not identify any registered systematic review protocols focusing on these aspects. To achieve optimal benefit and outcomes comparable to those observed in clinical trials, it is essential that NOACs are used appropriately by health professionals and patients. The evidence generated through systematic review will provide a robust and rigorous evidence base around appropriate use and hence best possible patient outcomes.